Collection and transmission of personal data by companies is required by law to monitor medicine safety. The guidance, which is intended to be a helpful reference for companies, covers the areas of:
receipt of safety data
safety data entry and transfers
rectification and objection rights
retention and redaction of personal data
security and notification.
The aims of the ABPI, PIPA and pvlegal in drafting this document were twofold, to help companies be compliant with their legal obligations for both pharmacovigilance and data protection but also to promote examples of good practice which should lead to better, more consistent protection of patients’ safety data in the UK.
You can access the full guidance document here.
Head of Regulatory Affairs